Current practices and harmonization challenges in Alzheimer’s disease biomarkers: an EFLM Committee: Harmonization Survey
Despite growing clinical adoption, AD biomarker testing remains highly heterogeneous. Coordinated international harmonization of pre-analytical procedures, analytical methods, and post-analytical interpretation, particularly for blood-based biomarkers, is urgently required to ensure reliable and comparable results.
Authors
- Lora Dukić (ORCID: https://orcid.org/0000-0001-6690-7551)
- Luisa Agnello
- Martina Zaninotto
- Leila Akvlediani
Institutions
- Batumi Shota Rustaveli State University (GE)
- University of Padua (IT)
- University of Rijeka (HR)
- University of Palermo (IT)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1515/cclm-2026-0168
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00